Novel Method for Mass Production of Recombinant Proteins Using MSG
On 30th May, 2024, researchers at the Indian Institute of Science (IISc) unveiled a novel method to mass produce recombinant proteins, including vaccine antigens and insulin, replacing hazardous methanol with mono-sodium glutamate (MSG).
- The new expression system aims to produce proteins for biotech industries, including milk and egg proteins, baby food supplements, nutraceuticals, and therapeutic molecules.
- An Indian patent has been granted, and a US patent has been filed for the novel expression system, with plans to collaborate with industry partners for scaling up production.
- The conventional method involves using methanol to activate yeast cells, which poses significant safety risks due to its ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Fresh Cases of Primary Amoebic Meningoencephalitis (PAM)
- 2 WHO Declares Hepatitis D as Carcinogenic
- 3 India Successfully Conducts First Integrated Air Drop Test (IADT-1)
- 4 Himalayan Outpost for Planetary Exploration (HOPE) in Ladakh
- 5 Bharatiya Antariksh Station (BAS) Module Unveiled
- 6 Successful Maiden Flight Tests of IADWS
- 7 AI Index 2025
- 8 NASA Unveils Surya AI Model to Decode Sun’s Behaviour
- 9 NASA’s Lunar Nuclear Reactor Plan
- 10 India’s First Indigenous Commercial EO Constellation
